Cristina Muniesa

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.

Patient and care partner burden in cutaneous T-cell lymphoma using disease-specific measures of symptoms and health-related quality of life.

Journal: The British journal of dermatology

Published: November 26, 2025

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.

Journal: The British journal of dermatology

Published: January 25, 2025

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Haematopoietic stem cell transplant in cutaneous T-cell lymphomas: A multicentre propensity-score matched study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 17, 2024

Early-stage mycosis fungoides: searching for biomarkers associated with advanced-stage progression.

Early-stage mycosis fungoides: searching for biomarkers associated with advanced-stage progression.

Journal: The British journal of dermatology

Published: August 20, 2024

[Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.

[Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.

Journal: Actas dermo-sifiliograficas

Published: October 17, 2023

Efficacy and safety of offline extracorporeal photopheresis in cutaneous T-cell lymphomas: A retrospective study.

Efficacy and safety of offline extracorporeal photopheresis in cutaneous T-cell lymphomas: A retrospective study.

Journal: Photodermatology, photoimmunology & photomedicine

Published: February 20, 2023

[Translated article] Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

[Translated article] Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.

Journal: Actas dermo-sifiliograficas

Published: November 02, 2022

Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: May 11, 2022

Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial.

Activity and safety of topical pimecrolimus in patients with early stage mycosis fungoides (PimTo-MF): a single-arm, multicentre, phase 2 trial.

Journal: The Lancet. Haematology

Published: January 14, 2022

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: June 01, 2021

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.

Journal: The British journal of dermatology

Published: May 22, 2020

Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.

Journal: Journal of the American Academy of Dermatology

Published: April 11, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026